Aptorum-backed DiamiR expands Alzheimer’s diagnostic efforts

AlzLabs collaboration comes as Aptorum and DiamiR prepare to become Niki BioSolutions, raising questions about future of brain diagnostics. Alzheimer’s disease develops silently over many years, yet confirming what’s happening inside the brain often requires some of medicine’s most expensive and least accessible tools. Amyloid PET scans, which can reveal hallmark Alzheimer’s pathology, remain the […] The post Aptorum-backed DiamiR expands Alzheimer’s diagnostic efforts appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.